Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Select Advanced Malignancies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT07541573
What this trial is testing

GTB-5550 in Advanced Solid Tumors

Who this might be right for
Tri-specific Killer EngagerSolid TumorAdvanced Solid Tumor
Masonic Cancer Center, University of Minnesota 175
Early research (Phase 1)Ended earlyNCT05977322
What this trial is testing

A Phase I Study of [177Lu]Lu-FF58 in Patients With Advanced Solid Tumors.

Who this might be right for
Pancreatic Ductal AdenocarcinomaGastroesophageal AdenocarcinomaGlioblastoma Multiforme
Novartis Pharmaceuticals 24
Testing effectiveness (Phase 2)Study completedNCT03836066
What this trial is testing

Atezolizumab Plus Bevacizumab in First Line NSCLC Patients

Who this might be right for
Non Small Cell Lung Cancer
Fundación GECP 41
Testing effectiveness (Phase 2)Active Not RecruitingNCT05631262
What this trial is testing

SKB264 Monotherapy in Selected Subjects With Advanced Solid Tumors

Who this might be right for
Selected Subjects With Advanced Solid Tumors
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. 321
Testing effectiveness (Phase 2)Study completedNCT02599324
What this trial is testing

Study to Evaluate Ibrutinib Combination Therapy in Patients With Selected Gastrointestinal and Genitourinary Tumors

Who this might be right for
Metastatic Renal Cell CarcinomaAdvanced Urothelial CarcinomaAdvanced Gastric Adenocarcinoma+1 more
Pharmacyclics LLC. 263
Testing effectiveness (Phase 2)Looking for participantsNCT04947254
What this trial is testing

Androgen Ablation Therapy With or Without Niraparib After Radiation Therapy for the Treatment of High-Risk Localized or Locally Advanced Prostate Cancer

Who this might be right for
Prostate CarcinomaStage IIC Prostate Cancer AJCC v8Stage III Prostate Cancer AJCC v8+4 more
M.D. Anderson Cancer Center 200
Testing effectiveness (Phase 2)Active Not RecruitingNCT06271837
What this trial is testing

T-DXd as Monotherapy or in Combination With Anti-cancer Agents in Patients With Selected HER2-expressing Tumors

Who this might be right for
Advanced Solid Tumors (Excluding Gastric Cancer and Breast Cancer)
AstraZeneca 127
Testing effectiveness (Phase 2)Study completedNCT04172454
What this trial is testing

Safety and Efficacy of AK104, a PD-1/CTLA-4 Bispecific Antibody, in Selected Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorsMelanoma
Akeso 68
Early research (Phase 1)Ended earlyNCT05576077
What this trial is testing

TBio-4101 (TIL) and Pembrolizumab in Patients With Advanced Solid Tumors

Who this might be right for
Breast CancerColorectal CancerUveal Melanoma+3 more
Turnstone Biologics, Corp. 31
Large-scale testing (Phase 3)Active Not RecruitingNCT03390504
What this trial is testing

Erdafitinib Compared With Vinflunine or Docetaxel or Pembrolizumab in Participants With Advanced Urothelial Cancer and Selected Fibroblast Growth Factor Receptor (FGFR) Gene Aberrations

Who this might be right for
Urothelial Cancer
Janssen Research & Development, LLC 629
Testing effectiveness (Phase 2)Active Not RecruitingNCT05358249
What this trial is testing

Platform Study of JDQ443 in Combinations in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation

Who this might be right for
KRAS G12C Mutant Solid TumorsCarcinoma, Non-Small Cell LungCarcinoma, Non-Small-Cell Lung+8 more
Novartis Pharmaceuticals 74
Early research (Phase 1)Study completedNCT02517398
What this trial is testing

MSB0011359C (M7824) in Metastatic or Locally Advanced Solid Tumors

Who this might be right for
Solid Tumors
EMD Serono Research & Development Institute, Inc. 600
Early research (Phase 1)Looking for participantsNCT05841563
What this trial is testing

Clinical Trial of PM54 in Advanced Solid Tumors Patients.

Who this might be right for
Advanced Solid Tumor
PharmaMar 125
Testing effectiveness (Phase 2)Looking for participantsNCT06114004
What this trial is testing

Selinexor Plus Gemcitabine in Selected Advanced Soft-tissue Sarcoma (SeliSarc)

Who this might be right for
Sarcoma,Soft Tissue
Asociación Europea y Latinoamericana SELNET para la Investigación en Sarcomas 88
Not applicableNot Yet RecruitingNCT06798246
What this trial is testing

HEFTME System for Adjuvant Therapeutic Selection of Locally Advanced UTUC Postoperatively：A Perspective Cohort Study

Who this might be right for
Upper Tract Urothelial Carcinoma
Peking University First Hospital 200
Early research (Phase 1)Ended earlyNCT05389462
What this trial is testing

Mipasetamab Uzoptirine (ADCT-601) in Participants With Solid Tumors

Who this might be right for
Advanced Solid Tumors
ADC Therapeutics S.A. 128
Early research (Phase 1)Study completedNCT05585034
What this trial is testing

Phase 1, First-in-human, Dose-finding and Expansion Study to Evaluate XmAb®808 in Combination With Pembrolizumab in Advanced Solid Tumors

Who this might be right for
Head and Neck Squamous Cell CarcinomaMelanoma Excluding Uveal MelanomaNon-small Cell Lung Cancer, Squamous or Non-squamous+6 more
Xencor, Inc. 60
Large-scale testing (Phase 3)Active Not RecruitingNCT06346392
What this trial is testing

AZD0901 Compared With Investigator's Choice of Therapy in Participants With Second- or Later-line Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Expressing Claudin18.2

Who this might be right for
Gastric CancerGastroesophageal Junction Cancer
AstraZeneca 594
Testing effectiveness (Phase 2)UnknownNCT05476965
What this trial is testing

Selected De-escalation Radiotherapy for Postoperative Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck Squamous Cell CarcinomaRadiotherapyImmunotherapy+1 more
Hubei Cancer Hospital 20
Large-scale testing (Phase 3)Study completedNCT03099382
What this trial is testing

Study of SHR-1210 Versus Investigator's Choice of Chemotherapy for Participants With Advanced Esophageal Cancer

Who this might be right for
Esophageal Carcinoma
Jiangsu HengRui Medicine Co., Ltd. 457
Next Page